Moreover, immunoblots using protein lysates of lung fibroblasts from IPF patients showed marked upregulation of TXNDC5 and αSMA proteins, compared with that from control subjects, in response to TGFβ1 treatment (Fig. 1c). The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.